FDAnews
www.fdanews.com/articles/138491-imacor-receives-ce-mark-for-claritee-probe

ImaCor Receives CE Mark for ClariTEE Probe

July 19, 2011
ImaCor has received a CE Mark for its ClariTEE Probe and Zura Systems, allowing for the marketing of these systems in Europe. ClariTEE is used to provide blood flow monitoring to seriously ill patients. It remain indwelling for up to 72 hours.